Tag Archives:myofibrillar myopathy
Discovery of Bag3-P209L signaling mechanism brings hope for therapeutic options currently in development
Myofibrillar myopathy (MFM) is a group of rare genetic disorders that cause both skeletal and cardiac muscle weakness. Mutations in the Bcl2-associated Athanogene 3 (Bag3) protein, highly expressed in striated muscle, are reported to cause a particularly
